NG
LLY icon

NatWest Group’s Eli Lilly LLY Stock Holding History

NatWest Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.96M Buy
+4,305
New +$4.36M 0.86% 39
2025
Q2 		– Sell
-283
Closed -$234K – 37
2025
Q1 		$234K Hold
283
– – 0.07% 33
2024
Q4 		$218K Sell
283
-13,952
-98% -$11.6M 0.06% 33
2024
Q3 		$12.6M Buy
14,235
+375
+3% +$337K 3.73% 10
2024
Q2 		$12.5M Buy
13,860
+26
+0.2% +$20.8K 4.29% 8
2024
Q1 		$10.8M Sell
13,834
-1,171
-8% -$833K 4.14% 7
2023
Q4 		$8.75M Sell
15,005
-2,333
-13% -$1.36M 3.66% 14
2023
Q3 		$9.31M Buy
17,338
+653
+4% +$336K 4.85% 5
2023
Q2 		$7.82M Buy
16,685
+193
+1% +$80.9K 4.07% 11
2023
Q1 		$5.66M Buy
16,492
+317
+2% +$107K 3.06% 16
2022
Q4 		$5.92M Buy
16,175
+61
+0.4% +$21.6K 3.36% 8
2022
Q3 		$5.21M Buy
+16,114
New +$5.11M 3.03% 11
2021
Q1 		– Sell
-3,003
Closed -$508K – 76
2020
Q4 		$508K Sell
3,003
-2,933
-49% -$438K 0.19% 59
2020
Q3 		$879K Hold
5,936
– – 0.19% 56
2020
Q2 		$975K Sell
5,936
-736
-11% -$113K 0.26% 41
2020
Q1 		$926K Buy
6,672
+736
+12% +$101K 0.26% 50
2019
Q4 		$780K Hold
5,936
– – 0.17% 62
2019
Q3 		$664K Sell
5,936
-750
-11% -$83.5K 0.16% 59
2019
Q2 		$741K Buy
6,686
+1,425
+27% +$168K 0.14% 58
2019
Q1 		$682K Sell
5,261
-4,150
-44% -$505K 0.14% 54
2018
Q4 		$1.09M Sell
9,411
-2,338
-20% -$261K 0.24% 46
2018
Q3 		$1.26M Sell
11,749
-920
-7% -$92K 0.23% 44
2018
Q2 		$1.08M Sell
12,669
-100
-0.8% -$8.21K 0.22% 46
2018
Q1 		$988K Sell
12,769
-1,430
-10% -$115K 0.21% 50
2017
Q4 		$1.2M Sell
14,199
-3,790
-21% -$322K 0.27% 45
2017
Q3 		$1.54M Sell
17,989
-31,719
-64% -$2.6M 0.38% 41
2017
Q2 		$4.09M Sell
49,708
-8,447
-15% -$689K 0.95% 26
2017
Q1 		$4.89M Sell
58,155
-10,915
-16% -$874K 1.04% 26
2016
Q4 		$5.08M Sell
69,070
-48,234
-41% -$3.59M 1.34% 23
2016
Q3 		$9.41M Buy
117,304
+34,953
+42% +$2.8M 2.22% 17
2016
Q2 		$6.49M Sell
82,351
-69,917
-46% -$5.26M 1.64% 20
2016
Q1 		$11M Sell
152,268
-11,058
-7% -$837K 2.45% 14
2015
Q4 		$13.8M Sell
163,326
-95,663
-37% -$7.94M 2.77% 11
2015
Q3 		$21.7M Buy
258,989
+2,100
+0.8% +$177K 0.49% 17
2015
Q2 		$21.4M Sell
256,889
-203
-0.1% -$15.5K 0.27% 16
2015
Q1 		$18.7M Sell
257,092
-6,255
-2% -$445K 0.25% 19
2014
Q4 		$18.2K Sell
263,347
-157,245
-37% -$10.6M 0.15% 22
2014
Q3 		$27.3K Sell
420,592
-29,988
-7% -$1.9M 0.23% 18
2014
Q2 		$28M Sell
450,580
-36,526
-7% -$2.18M 1.18% 16
2014
Q1 		$28.7M Sell
487,106
-74,065
-13% -$4.13M 1.27% 15
2013
Q4 		$28.6M Buy
561,171
+56,066
+11% +$2.81M 0.73% 30
2013
Q3 		$25.4M Sell
505,105
-222,972
-31% -$11.7M 0.74% 26
2013
Q2 		$35.8M Buy
+728,077
New +$39.6M 0.51% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NatWest Group's LLY Position: Q1 2026 in Review

NatWest Group opened a new position in Eli Lilly (LLY) in Q1 2026: 4,305 shares worth $3.96M. The stake represents 0.86% of the portfolio and ranks #39 among its holdings. This is a return to the name: NatWest Group previously reported a position in LLY as recently as Q1 2025.

NatWest Group first reported a position in LLY in Q2 2013 and has held it in 43 quarters since. The position peaked at $35.8M in Q2 2013. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • NatWest Group held 4,305 shares of Eli Lilly worth $3.96M as of Q1 2026.
  • Eli Lilly was a new NatWest Group position in Q1 2026.
  • Eli Lilly made up 0.86% of NatWest Group's portfolio in Q1 2026, its #39 holding.
  • NatWest Group first reported a position in Eli Lilly in Q2 2013 and has held it in 43 quarters since.
  • NatWest Group's Eli Lilly position peaked at $35.8M in Q2 2013.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on NatWest Group's 13F filing for Q1 2026, filed 11 May 2026.